Presentation and Outcome of Management of Parotid Tumors: A Local Experience from Two Sudanese States

  • Sami E E Salah MD. Associate Professor of Surgery
  • Sami Galal-eldin E Mohammed MD, MRCS, CABS. Assistant Professor of Surgery - Gadarif University, Department of Surgery – Gadarif Teaching Hospital
  • Rehab Elmushly General Surgeon MOH, Gadarif Teaching Hospital

Abstract

Parotid tumors are rare but good amount of knowledge is required to preserve the facial nerve during   superficial or deep parotidectomy.  This is a study of 49 patients   who presented with parotid tumors in the last 12 year with a mean age of 44 yrs. Parotid lump was the main symptom in all patients, while facial nerve palsy was the presenting symptom in only 4.1%. In this study 69.3% of patients   underwent superficial parotidectomy while 30.6% had total parotidectomy. Transient facial nerve palsy occurred in   22.4% while permanent damage occurred in (8.1%) of patients. Pleomorphic adenoma represented 91.8% of benign tumors while mucoepidermoid tumors represented 41.6% of malignant tumors making them the two most common pathological diagnoses. Recurrence occurred in only 3 patients

References

1. Spiro R, Spiro J. Cancer of the salivary glands. In: Meyers E, Suen J, editors. Cancer of the head and neck. New York: Churchill Livingstone; 1984. pp. 645.
2. Zbaren P, Schar C, Hotz MA, et al. Value of fine-needle aspiration cytology of parotid gland masses. Laryngoscope. 2001;111:1989–92.
3. Sergi B, Contucci AM, Corina L, et al. Value of fine-needle aspiration cytology of parotid gland masses. Laryngoscope. 2004;114: 789.
4. Contucci AM, Corina L, Sergi B, et al. Correlation between fine needle aspiration biopsy and histologic findings in parotid masses. Personal experience. Acta Otorhinolaryngol Ital. 2003;23:314–18
5. PM, McGarry G, Shaw-Dunn J, et al. The precision of four commonly used surgical landmarks for locating the facial nerve in anterograde parotidectomy in humans. Ann Anat. 2010;192: 27–32.
6. Redaelli de Zinis LO, Piccioni M, Antonelli AR, et al. Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature. Eur Arch Otorhinolaryngol. 2008;265:447–452.
7. Heller KS, Attie JN, et al. Treatment of Warthin's tumor by enucleation. Am J Surg. 1988;156: 294–296
8. Speight PM, Barrett AW: Salivary gland tumors. Oral Dis 8 (5): 229-40, 2002.
9. Mendenhall WM, Werning JW, Pfister DG: Treatment of head and neck cancer. In: DeVita VT Jr, Lawrence TS, Rosenberg SA: Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2011, pp 729-80.
10. Gooden E, Witterick IJ, Hacker D, et al: Parotid gland tumors in 255 consecutive patients: Mount Sinai Hospital's quality assurance review. J Otolaryngol 31 (6): 351-4, 2002.
11. Guzzo M, Andreola S, Sirizzotti G, et al: Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol 9 (7): 688-95, 2002.
12. O'Brien CJ. Current management of benign parotid tumors--the role of limited superficial parotidectomy. Head Neck 2003; 25:946.
13. Helmus C. Subtotal parotidectomy: a 10-year review (1985 to 1994). Laryngoscope 1997; 107:1024.
14. Stennert E, Wittekindt C, Klussmann JP, et al. Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study. Laryngoscope 2004; 114:158.
15. Leverstein H, van der Wal JE, Tiwari RM, et al. Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg 1997; 84:399.
16. Wennmo C, Spandow O, Emgård P, Krouthén B. Pleomorphic adenomas of the parotid gland: superficial parotidectomy or limited excision? J Laryngol Otol 1988; 102:603.
17. Guntinas-Lichius O, Klussmann JP, Schroeder U, et al. Primary parotid malignoma surgery in patients with normal preoperative facial nerve function: outcome and long-term postoperative facial nerve function. Laryngoscope 2004; 114:949.
18. Sullivan MJ, Breslin K, McClatchey KD, et al. Malignant parotid gland tumors: a retrospective study. Otolaryngol Head Neck Surg 1987; 97:529.
19. Bendet E, Talim YP, Kronenburg J. Preoperative electroneurography (ENoG) in parotid surgery. Head Neck 1998; 20: 124-31.
20. Levan P, De Cerverlier, Revol M, Servant JM. Lipoma of the superficial lobe of the parotid gland: A case report. Ann Chir Plast Esthet 1997; 42: 313-7.
21. Watkin GT, Mc Lean JK, Hobsley M. Lymphoma presenting as lump in the parotid region. Br J Surg 1984; 71: 701-2.
22. Abulhassan M, Sharif MS. Pattern and clinical presentation of Hodgkin’s disease in Radioactive and Isotope Centre of Khartoum (RICK). 1989 (Thesis).page 44.
23. Christensen N R et al. Benign neoplasm in the parotid gland in the county of Copenhagen 1985-1996. Underskirt Leager 1998; 160: 6066-9.
24. Patel N, Poole A. Recurrent benign parotid tumor: the lesson not learnt yet? Aus N Z J Surg 1998; 68: 568-74.
25. Watkin G T, Hobsley M. Should radiotherapy be used routinely in the management of benign parotid tumor? Br J Surg 1986; 73: 601-3.
26. Magnano M, et al. Therapeutic strategies for treatment of parotid gland malignancies. Aeta Otolaryngol Ital 1998; 18: 164-71.
27. Takaichi N, Hirose F, Yamamato H. Salivary gland tumors in atomic bomb survivors, Hiroshima. Japan Cancer 1976; 38: 2462-8.
28. Leverstein H. et al. Malignant epithelial parotid gland tumor: analysis and result in 65 previously untreated patients. Br J Surg 1998; 85: 1267-72
Published
2015-06-01
How to Cite
E E SALAH, Sami; E MOHAMMED, Sami Galal-eldin; ELMUSHLY, Rehab. Presentation and Outcome of Management of Parotid Tumors: A Local Experience from Two Sudanese States. Gezira Journal of Health Sciences, [S.l.], v. 11, n. 1, june 2015. ISSN 1810-5386. Available at: <http://37.60.236.48/index.php/gjhs/article/view/386>. Date accessed: 03 june 2026.
Section
Articles